BACKGROUND: The experiences of women with vulvodynia are poorly understood. OBJECTIVE: We sought to determine the effects of vulvodynia on quality of life. METHODS: We conducted a survey of 280 patients in a university-based vulvar disorders clinic. Skin-related quality of life was measured with a vulvar-specific version of Skindex-29. RESULTS: The response rate was 95%; 101 patients (36%) had vulvodynia, and 179 patients (64%) had other vulvar conditions. Women with vulvodynia had significantly worse quality of life than patients with many other dermatologic conditions, and worse functioning than women with other vulvar conditions (mean functioning scores [+/-SD] of patients with psoriasis, other vulvar conditions, and vulvodynia were 23 +/- 27, 34 +/- 24, and 44 +/- 22, respectively, P = .05). A diagnosis of vulvodynia was the strongest independent correlate of poor quality of life (eg, for poor functioning, odds ratio = 1.8, 95% confidence interval 1.0-3.1). LIMITATIONS: Limitations are single academic medical center and comorbid illnesses determined by self-report. CONCLUSION: Vulvodynia has broad and substantial effects on quality of life.
BACKGROUND: The experiences of women with vulvodynia are poorly understood. OBJECTIVE: We sought to determine the effects of vulvodynia on quality of life. METHODS: We conducted a survey of 280 patients in a university-based vulvar disorders clinic. Skin-related quality of life was measured with a vulvar-specific version of Skindex-29. RESULTS: The response rate was 95%; 101 patients (36%) had vulvodynia, and 179 patients (64%) had other vulvar conditions. Women with vulvodynia had significantly worse quality of life than patients with many other dermatologic conditions, and worse functioning than women with other vulvar conditions (mean functioning scores [+/-SD] of patients with psoriasis, other vulvar conditions, and vulvodynia were 23 +/- 27, 34 +/- 24, and 44 +/- 22, respectively, P = .05). A diagnosis of vulvodynia was the strongest independent correlate of poor quality of life (eg, for poor functioning, odds ratio = 1.8, 95% confidence interval 1.0-3.1). LIMITATIONS: Limitations are single academic medical center and comorbid illnesses determined by self-report. CONCLUSION:Vulvodynia has broad and substantial effects on quality of life.
Authors: Elisabeth A Erekson; Sallis O Yip; Terri S Wedderburn; Deanna K Martin; Fang-Yong Li; Jennifer N Choi; Kimberly S Kenton; Terri R Fried Journal: Menopause Date: 2013-09 Impact factor: 2.953
Authors: Hope K Haefner; Nely Z Aldrich; Vanessa K Dalton; Hélène M Gagné; Stephanie B Marcus; Divya A Patel; Mitchell B Berger Journal: J Womens Health (Larchmt) Date: 2014-08-27 Impact factor: 2.681
Authors: Candace S Brown; David C Foster; Jim Y Wan; Leslie A Rawlinson; Gloria A Bachmann Journal: Contemp Clin Trials Date: 2013-06-29 Impact factor: 2.226
Authors: Julia C Bond; Jacob J Kachura; Matthew P Fox; Jennifer Weuve; Bernard L Harlow Journal: J Womens Health (Larchmt) Date: 2021-06-29 Impact factor: 2.681